CytomX raises $11M in series B extension

CytomX Therapeutics Inc. (South San Francisco, Calif.) raised $11 million in an extension of a series B round, bringing the total raised in the round to $41 million. New investor Canaan Partners led the extension with participation from existing investors Third Rock Ventures and Roche Venture Fund. Canaan's Tim Shannon will join CytomX's board. ...